Physician profile
Shaun Bhatty
NPI 1316107154
$8,282.65
in general payments reported to CMS, 2019-2025
23 companies · $918 in 2025
The $918 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $1,702 · 2021: $747 · 2022: $691 · 2023: $1,037 · 2024: $2,866 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,874 · Consulting Fee: $1,125 · Travel and Lodging: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,873.81 |
| Consulting Fee | $1,125.00 |
| Travel and Lodging | $822.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,760.93 | 2019-2025 | Resonate El Icd Vr, Watchman Flx, Endotak Reliance S |
| Altathera Pharmaceuticals LLC | $1,150.03 | 2024-2025 | Sotalol Hydrochloride |
| Biosense Webster, INC. | $616.69 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Medtronic, INC. | $451.22 | 2021-2025 | Selectsecure, Micra, Symplicity G3 |
| Medtronic Vascular, INC. | $423.88 | 2019-2020 | |
| Atricure, INC. | $185.94 | 2022-2023 | |
| Philips North America LLC | $109.01 | 2024-2025 | Igt Devices Undivided, (9278) Bridge |
| Astrazeneca Pharmaceuticals Lp | $67.45 | 2020-2022 | |
| Amgen INC. | $62.28 | 2020-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $61.59 | 2024-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $57.91 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $44.62 | 2020-2022 | |
| Biotronik INC. | $40.81 | 2019 | |
| Angiodynamics, INC. | $39.82 | 2021 | |
| Abbott Laboratories | $37.94 | 2021-2023 | Aveir |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.29 | 2021-2022 | |
| Edwards Lifesciences Corporation | $27.53 | 2024 | Hemosphere |
| Kestra Medical Technology Services, INC. | $25.36 | 2025 | Assure Wcd |
| Convatec INC. | $24.68 | 2024 | |
| Amarin Pharma, INC. | $18.25 | 2020 | |
| Siemens Medical Solutions USA, INC. | $14.69 | 2020 | |
| Elutia, INC. | $14.39 | 2023 | |
| Cordis US Corp. | $14.34 | 2024 | Brite Tip Radianz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Bhatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.